[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"outpatient\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:outpatient":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,48,81,112,150],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100635640","outpatient-midline-catheter-in-patients-receiveing-lidocaine-infusion-series-100635640",false,"NCT07555314","Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.","Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Therapy. A Prospective, Observational Study.","Midline Lid","Inclusion Criteria:\n\n* Patients qualified for lidocaine infusion therapy due to the chronic pain\n* Able to provide consent\n* ≥18 years of age\n\nExclusion Criteria:\n\n* Lack of patient consent","ALL","18 Years",{"count":20,"type":21},500,"ESTIMATED","10 Days","OBSERVATIONAL","This study will assess the efficacy, safety and practicality of using midline catheters for repeated intravenous lidocaine infusions in an outpatient pain management setting. Adult patients requiring serial lidocaine infusions for chronic pain will be enrolled and receive treatment through midline catheters over ten sessions.\n\nThe study will investigate if the midline catheters are a safe and effective option for delivering repeated lidocaine infusions in the outpatient setting, offering a balance between ease of placement, acceptable complication risk and good patients' comfort.",[26,27,28,29],"Midline Catheter","Lidocaine Infusion","Chronic Pain","Outpatient",[31,32,33,34],"midline catheter","lidocaine infusion","chronic pain","outpatient","RECRUITING","2026-04-21",{"date":38,"type":39},"2026-04-29","ACTUAL",{"date":41,"type":21},"2026-04-20",{"date":43,"type":21},"2028-06-01",{"name":45,"class":46},"Medical University of Warsaw","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":17,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":47},"100419583","rsv-burden-in-outpatient-and-hospital-settings-100419583","NCT04743609","RSV Burden in Outpatient and Hospital Settings","Ambulatory Respiratory Tract Infection Survey, Burden of Respiratory Syncitial Virus in the Era of Covid-19","Oursyn","Inclusion Criteria:\n\n* children under 24 months of age (≤)\n* One of the holders of parental authority signed the consent\n* Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage)\n* Acute purulent otitis media (Paradise Criteria) or otorrhea with or withitout associated bronchiolitis\n\nExclusion Criteria:\n\n* Age \\>24 months\n* Refusal by one of the parents\n* Not affiliated to a social security system\n* Maternal RSV vaccination during the pregnancy of the included child","1 Day","24 Months",{"count":59,"type":21},1900,"INTERVENTIONAL",[62],"NA","Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)",[65,66,29,67],"RSV Infection","Children, Only","Otitis",[69,70,71],"RSV","children","otitis with or without concomitant bronchiolitis","2026-03-17",{"date":74,"type":39},"2026-03-19",{"date":76,"type":39},"2021-02-08",{"date":78,"type":21},"2026-12-08",{"name":80,"class":46},"Association Clinique Thérapeutique Infantile du val de Marne",{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":88,"targetDuration":4,"studyType":60,"phases":90,"briefSummary":91,"conditions":92,"keywords":99,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":47},"100629062","multidisciplinary-care-pathway-tailored-on-frailty-in-cancer-patients-referred-to-outpatient-palliative-care-100629062","NCT07469761","MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care","MISTRAL","Inclusion Criteria:\n\n* diagnosis of advanced\u002Fmetastatic cancer\n* age \\> 18\n* Eastern Cooperative Oncology Group (ECOG) performance status ≥2\n* prognostic clinical prediction \\>1 month.\n\nExclusion Criteria:\n\n* Serious medical or psychiatric illness that can interfere with informed consent and participation in this clinical study\n* any condition that is unstable or could jeopardize the safety of the patient and their compliance in the study.",{"count":89,"type":21},120,[62],"The goal of this clinical trial is to learn whether a structured, Patient-Reported Outcome Measures (PROMs)-tailored palliative care pathway improves clinical outcomes and care experience in adults with advanced cancer referred to outpatient palliative care.\n\nPatients with advanced cancer often experience multiple symptoms and complex needs. Standard outpatient palliative care is usually guided by clinical judgment on patient-reported questionnaires. In this study, researchers aim to test whether a more structured approach, based on predefined cut-offs from PROMs, can improve symptom control, satisfaction with care, and use of healthcare resources. The main questions the study aims to answer are:\n\nDoes a structured, PROM-driven palliative care pathway reduce symptom burden and psychological distress compared with usual care? And through this, to improve patients' and caregivers' satisfaction with care or reduce emergency room visits, hospital admissions, healthcare costs, and aggressive treatments near the end of life?\n\nResearchers will compare two groups:\n\nControl group: Participants will receive standard outpatient palliative care. PROMs are collected as usual, but without predefined cut-offs or structured intervention checklists.\n\nExperimental group: Participants will receive a structured palliative care pathway tailored to symptoms\u002Fneeds identified at baseline using PROM cut-offs. Specific multidisciplinary interventions are activated according to identified needs.",[93,94,95,96,97,98,29],"Palliative Care","Palliative Care, Health Services","Patient Reported Outcome (PRO)","Patient Reported Outcome Measurements","Frailty","Cancer",[100,29,93,101,97,102],"Patient Reported Outcome Measurements (PROMs)","Advanced cancer","Palliative Care intervention","2026-03-09",{"date":105,"type":39},"2026-03-13",{"date":107,"type":39},"2025-11-02",{"date":109,"type":21},"2027-02-28",{"name":111,"class":46},"Augusto Caraceni",{"id":113,"slug":114,"hasResults":11,"nctId":115,"briefTitle":116,"officialTitle":117,"acronym":4,"eligibilityCriteria":118,"healthyVolunteers":11,"sex":17,"minAge":119,"maxAge":4,"enrollmentInfo":120,"targetDuration":4,"studyType":60,"phases":122,"briefSummary":123,"conditions":124,"keywords":131,"overallStatus":139,"whyStopped":4,"lastUpdateSubmitDate":140,"lastUpdatePostDateStruct":141,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":4},"100628632","evaluation-of-dora-care-for-supporting-fracture-liaison-services-fls-100628632","NCT07464171","Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)","A Prospective, Mixed-Methods Feasibility Study to Evaluate the Agreement, Safety, and Acceptability of 'Dora Care', an Automated AI Voice Assistant, for Supporting Clinical Pathways in a Fracture Liaison Service.","Inclusion Criteria:\n\n* Access to and ability to use a telephone for automated conversations as part of a routine, FLS phone pathway. This includes patients who are:\n* Adults aged ≥50 years.\n* Presenting with a new fragility fracture requiring FLS assessment.\n* Able to provide informed consent.\n* English speaking.\n* Reside in the UK.\n\nExclusion Criteria:\n\n* Severe cognitive impairment precluding meaningful telephone interaction or informed consent.\n* Patients already established on long-term osteoporosis treatment.\n* Terminal illness with a life expectancy \\\u003C12 months.\n* Current participation in another clinical trial altering standard of care thus altering the care schedule.","50 Years",{"count":121,"type":21},217,[62],"What is the study about? This study is testing \"Dora\", an AI-powered assistant that can make phone calls to patients, for use in the Fracture Liaison Service (FLS). The FLS is a clinic that helps prevent more bone fractures after an initial \"fragility fracture\" (a break that happens easily, usually due to osteoporosis).\n\nWhy is this being done? FLS clinicians often have to spend a lot of time on routine phone calls for assessments and follow-ups. If Dora can safely and accurately collect patient information, it might save time for staff and still give patients a good experience.\n\nWhat will happen to patients in the study? Invitation and consent - Patients with a new fragility fracture who are eligible will be invited to take part after informed consent.\n\nDora call - Patients will receive an automated phone call from Dora, at the start of their FLS pathway and at follow-up.\n\nAt intake, Dora will ask about risk factors for bone problems (e.g., smoking, alcohol use, family fracture history).\n\nAt follow-up, Dora will ask about medication use, side effects, falls, or new fractures.\n\nClinician call - Soon after, patients will have their usual phone appointment with an FLS clinician, who asks similar questions.\n\nSurveys\u002Finterviews - Patients will be asked to complete a short questionnaire and take part in an optional interview to say how they felt about talking to Dora.\n\nWhat about clinicians? Clinicians involved in the FLS pathway will be asked to complete a short survey and to take part in an optional interview to understand how useful Dora's reports might be in their work.\n\nWho can take part? Patients - Age 50+, English-speaking, with a new fragility fracture, and able to use the phone.\n\nClinicians - Those working in FLS or similar bone health services. How long will it take? Each patient might be involved for up to about 7 months. The whole study will take about a year.",[125,126,29,127,128,129,130],"AI (Artificial Intelligence)","Osteoporosis","Telemedicine","Automation","Risk Assesment","Bone Health",[125,132,133,134,135,136,127,130,137,138],"Fracture Liason Services","Conversational AI","Triage","Rheumatology","Telephone Consultation","Voice AI","Medical Device","NOT_YET_RECRUITING","2026-03-05",{"date":142,"type":39},"2026-03-11",{"date":144,"type":21},"2026-02",{"date":146,"type":21},"2027-12",{"name":148,"class":149},"Ufonia","INDUSTRY",{"id":151,"slug":152,"hasResults":11,"nctId":153,"briefTitle":154,"officialTitle":155,"acronym":4,"eligibilityCriteria":156,"healthyVolunteers":157,"sex":17,"minAge":18,"maxAge":158,"enrollmentInfo":159,"targetDuration":4,"studyType":60,"phases":161,"briefSummary":162,"conditions":163,"keywords":165,"overallStatus":139,"whyStopped":4,"lastUpdateSubmitDate":173,"lastUpdatePostDateStruct":174,"startDateStruct":176,"completionDateStruct":178,"leadSponsor":180,"locationsCount":47},"100621755","effect-of-interactive-video-based-self-management-education-in-adults-with-type-2-diabetes-100621755","NCT07374744","Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes","The Effect Of An Interactive Video-Based Self-Management Education On Glycemic Control, Self-Management and Empowerment İn Individuals With Type 2 Diabetes: A Parallel-Group, Single-Blind, Randomized Controlled Trial","Inclusion Criteria:\n\n* Aged between 18 and 65 years (Mumcu \\& İnkaya, 2022).\n* Able to read, write, understand, and speak Turkish.\n* Diagnosed with type 2 diabetes for at least one year (Onyia et al., 2023; Shahshahani et al., 2023).\n* Receiving oral antidiabetic agents and\u002For insulin therapy (Mikhael et al., 2019).\n* Having an HbA1c level \\>7% in at least one measurement within the last 3 months (Hu et al., 2023; Lee et al., 2020; Asmat et al., 2023; TEMD, 2024).\n* Volunteering to participate in the study.\n* Owning a personal device (e.g., smartphone) capable of playing interactive videos.\n* Having the ability to use a smartphone capable of playing interactive videos, which will be assessed by observing the participant using an interactive video -not related to the study intervention.\n* Owning a smartphone with an active internet data plan.\n* Being able to attend scheduled follow-up visits at the frequency required for study measurements.\n* Having a body mass index (BMI) ≥18.5 kg\u002Fm² (Lee et al., 2022).\n* Not following a vegan or vegetarian diet (Dening et al., 2023).\n* Having hemoglobin levels within normal ranges (women: 12-16 g\u002FdL; men: 14-18 g\u002FdL) (Billett, 1990).\n\nExclusion Criteria:\n\n* Having previously received video-based diabetes education.\n* Currently using or having previously used a video-based tool or program supporting type 2 diabetes management.\n* Having severe visual, auditory, cognitive impairments, or physical disabilities that may interfere with participation.\n* Being hospitalized as an inpatient during the intervention period.\n* Being pregnant, planning pregnancy within the next 6 months, or becoming pregnant during the study.\n* Breastfeeding during the study period (due to potential dietary restrictions).\n* Using any weight-loss medication or supportive pharmacological agent.\n* Having a diagnosis of sickle cell anemia or being diagnosed during the study period (TEMD, 2024, p.18; Eyth et al., 2025).\n* Receiving hemodialysis, having experienced recent bleeding or blood transfusion, or receiving erythropoietin therapy (TEMD, 2024, p.18; Eyth et al., 2025).\n* Having a diagnosed psychiatric disorder (e.g., major depressive disorder, bipolar disorder, schizophrenia).\n* Participating in another diabetes-related intervention or program during the study period.\n* Using an insulin pump (Lee et al., 2022).\n* Managing diabetes with nutrition therapy alone without pharmacological treatment.\n* Following a diet prescribed and supervised by a dietitian due to another medical condition or surgical procedure.",true,"65 Years",{"count":160,"type":21},60,[62],"This study aims to evaluate the effectiveness of an interactive video-based self-management education program for adults with type 2 diabetes. The education program is designed to support individuals in managing their daily diabetes care and improving their blood glucose control. Participants in this study will be adults diagnosed with type 2 diabetes who are receiving outpatient care. Eligible participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will receive an interactive video-based education program developed according to the AADE7 Self-Care Behaviors framework. The videos are based on real-life scenarios and encourage active participation and decision-making. Participants in the control group will receive standard diabetes care. The study will assess changes in blood glucose control, diabetes self-management behaviors, and empowerment levels over the study period. Data will be collected using clinical measurements and questionnaires. Participation in this study is voluntary. The results of this study may contribute to improving diabetes education practices and supporting patient-centered care in clinical settings.",[164,29],"Type 2 Diabetes",[166,167,168,169,170,171,172],"type 2 diabetes mellitus","self management","video recording","education","nursing","empowerment","quality of life","2026-01-21",{"date":175,"type":39},"2026-01-29",{"date":177,"type":21},"2026-08-01",{"date":179,"type":21},"2026-11-30",{"name":181,"class":46},"Abant Izzet Baysal University"]